MFN Drug Pricing Targets: Lowering U.S. Drug Co...

By Rene Pretorius

May 21, 2025

Summary The U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) have set Most-Favored-Nation (MFN)
HTA Reform Analysis: Patterns and Global Trends in Health Technology Assessment
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
Prevention Valuation: Fund Health, Not Just Savings
FDA AI Drug Approval
Implementing Health Technology Assessment in Oman
Empowering Health: The Role of Self-Care and NCDs in Global Health Policy
Assessing Risks and Opportunities: The Impact of the CDC Hepatitis Lab Closure
Defunding Scientific Research: Implications and Misconceptions in GawandeR...
Optimizing Value-Based Drug Pricing in Japan with MARIE Framework
Navigating Drug Price Regulation: Evaluating the Executive Order’s Pote...